Search - tctmd.com

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

Advertisement

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Baseline Anemia Raises Risk for Stent Thrombosis After DES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Better Clopidogrel Response Seen with Increased Smoking Levels

TCTMD’s Top 10 Most Popular News Stories From 2011

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

Similar Mortality Rates Seen in Men and Women with NSTE ACS

PROFI Published: Better Cerebral Protection with Balloon Occlusion after CAS

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content